At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
PLRZ Polyrizon Ltd.
Market Closed 12-20 16:00:00 EST
1.57
-0.76
-32.62%
盘后1.57
+0.000.00%
19:57 EST
High2.19Low1.26Vol1.38M
Open2.00D1 Closing2.33Amplitude39.91%
Mkt Cap6.59MTradable Cap1.57MTotal Shares4.19M
T/O2.43MT/O Rate137.79%Tradable Shares1.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
Polyrizon appoints Michal Meir as senior director, regulatory & clinical affairs
TIPRANKS  ·  12-19
Polyrizon appoints Michal Meir as senior director, regulatory & clinical affairs
Polyrizon Appoints DR. Michal Meir as Senior Director of Regulatory and Clinical Affairs
THOMSON REUTERS  ·  12-19
Polyrizon Appoints DR. Michal Meir as Senior Director of Regulatory and Clinical Affairs
Press Release: Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs
Dow Jones  ·  12-19
Press Release: Polyrizon Appoints Dr. Michal Meir as Senior Director of Regulatory and Clinical Affairs
Polyrizon Shares Surge on Impending Clinical Trial
Dow Jones  ·  12-19
Polyrizon Shares Surge on Impending Clinical Trial
Polyrizon Collaborating With Eurofins CDMO for Clinical Trial of Allergy Blocker; Shares Jump
MT Newswires Live  ·  12-18
Polyrizon Collaborating With Eurofins CDMO for Clinical Trial of Allergy Blocker; Shares Jump
Polyrizon's Moving Forward With Expected 2025 Clinical Trial - Entered Manufacturing Agreement for Its Pl-14 Allergy Blocker
THOMSON REUTERS  ·  12-18
Polyrizon's Moving Forward With Expected 2025 Clinical Trial - Entered Manufacturing Agreement for Its Pl-14 Allergy Blocker
Polyrizon Announces Appointment of Vp of Regulatory Affairs and Quality Assurance
THOMSON REUTERS  ·  12-13
Polyrizon Announces Appointment of Vp of Regulatory Affairs and Quality Assurance
Polyrizon Announces Appointment of VP of Regulatory Affairs and Quality Assurance
GlobeNewswire  ·  12-13
Polyrizon Announces Appointment of VP of Regulatory Affairs and Quality Assurance
Polyrizon Enters Into Gmp Manufacturing Agreement for Ctm Supply of Its Pl-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
THOMSON REUTERS  ·  12-02
Polyrizon Enters Into Gmp Manufacturing Agreement for Ctm Supply of Its Pl-14 Allergy Blocker in Preparation for Planned 2025 Clinical Trial
Aegis Capital Corp. Acted as Sole Bookrunner on a $4.2 Million (IPO) Initial Public Offering for Polyrizon Ltd. (NASDAQ: PLRZ)
ACCESSWIRE  ·  10-31
Aegis Capital Corp. Acted as Sole Bookrunner on a $4.2 Million (IPO) Initial Public Offering for Polyrizon Ltd. (NASDAQ: PLRZ)
BRIEF-Polyrizon Announces Closing Of $4.2 Mln IPO
Reuters  ·  10-30
BRIEF-Polyrizon Announces Closing Of $4.2 Mln IPO
Polyrizon opens at $1.64, IPO priced at $4.38 per unit
TIPRANKS  ·  10-30
Polyrizon opens at $1.64, IPO priced at $4.38 per unit
Polyrizon Announces Closing of $4.2 Million Initial Public Offering
THOMSON REUTERS  ·  10-30
Polyrizon Announces Closing of $4.2 Million Initial Public Offering
Polyrizon Announces Closing of $4.2 Million Initial Public Offering
GlobeNewswire  ·  10-30
Polyrizon Announces Closing of $4.2 Million Initial Public Offering
Top Midday Decliners
MT Newswires Live  ·  10-30
Top Midday Decliners
Polyrizon Shares Sink in Nasdaq Debut
MT Newswires Live  ·  10-30
Polyrizon Shares Sink in Nasdaq Debut
Polyrizon Prices $4.2 Million IPO
MT Newswires Live  ·  10-29
Polyrizon Prices $4.2 Million IPO

Introduction

Company Name.
Polyrizon Ltd.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--